Since Dec. 1, 2018, the S&P 500 fell 11 percent, as of Dec. 31, 2018. The stock market has had its worst December since the Great Depression. America’s trade war with China, interest rates and uncertainty in government policy all helped to create a loss of more than 10 percent, as of Dec. 27. Dec. 4, 2018
Full Answer
What is the ticker symbol for Direxion daily S&P biotech bear 3x shares?
Direxion Daily S&P Biotech Bear 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LABD." How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares? Shares of LABD can be purchased through any online brokerage account.
How much did shares of shares decline in 2018?
Shares declined 26.5% in value in 2018, according to data provided by S&P Global Market Intelligence. As a result, they underperformed the S&P 500, which lost only 6.35% in value last year.
How much has the stock market fallen since the Great Depression?
Since Dec. 1, 2018, the S&P 500 fell 11 percent, as of Dec. 31, 2018. The stock market has had its worst December since the Great Depression. America’s trade war with China, interest rates and uncertainty in government policy all helped to create a loss of more than 10 percent, as of Dec. 27. Dec. 4, 2018
Why did the stock market fall 11 percent in 2018?
Hover or tap chart for more detail Since Dec. 1, 2018, the S&P 500 fell 11 percent, as of Dec. 31, 2018. The stock market has had its worst December since the Great Depression. America’s trade war with China, interest rates and uncertainty in government policy all helped to create a loss of more than 10 percent, as of Dec. 27.
What caused GUSH stock to drop?
Bull 2X Shares ETF (GUSH) fell by over 97% during the first 11 months of 2020. This terrible performance can be traced to a collapse in oil prices caused by a supply glut due to a price war between Saudi Arabia and Russia and a dramatic drop in demand driven by the global crisis.
Should I hold GUSH stock?
GUSH holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this ETF.
Why 3x ETFs are wealth destroyers?
Triple-leveraged (3x) exchange-traded funds (ETFs) come with considerable risk and are not appropriate for long-term investing. Compounding can cause large losses for 3x ETFs during volatile markets, such as U.S. stocks in the first half of 2020.
Can GUSH stock recover?
GUSH: Global Energy's Rebound Likely To Produce Returns In 2021.
Is GUSH expected to rise?
Technical Analysis (Indicators) GUSH moved below its 50-day moving average on June 16, 2022 date and that indicates a change from an upward trend to a downward trend. The Aroon Indicator for GUSH entered a downward trend on July 13, 2022. This could indicate a strong downward move is ahead for the stock.
What stocks make up GUSH?
Top 10 HoldingsCompanySymbolTotal Net AssetsDreyfus Government Cash Management Institutional ShsDGCXX42.10%Financial Square Treasury Instruments Fund FST SharesFTIXX11.31%EQT Corp.EQT1.45%Southwestern Energy Co.SWN1.35%6 more rows
Why should you not hold leveraged ETFs?
Bottom line: Leveraged and inverse ETFs work well for day-traders, but because of compounding and tracking error these ETFs work poorly when the market turns volatile. They are not good buy-and-hold investments.
How long can you hold a 3x ETF?
A trader can hold the majority of these ETFs including TQQQ, FAS, TNA, SPXL, ERX, SOXL, TECL, USLV, EDC, and YINN for 150-250 days before suffering a 5% underperformance although a few, like NUGT, JNUG, UGAZ, UWT, and LABU are more volatile and suffer a 5% underperformance in less than 130 days and, in the case of JNUG ...
Do all leveraged ETFs go to zero?
When based on high-volatility indexes, 2x leveraged ETFs can also be expected to decay to zero; however, under moderate market conditions, these ETFs should avoid the fate of their more highly leveraged counterparts.
Did gush have a reverse split?
Massive Reverse Splits Announced On Tuesday, Direxion announced a 1-for-40 reverse split for GUSH, as well as a 1-for-10 split for the more broadly based Direxion Daily Energy Bull 3x Shares (ERX), and a whopping 1-for-100 split for GASL.
Will DRIP stock go back up?
Based on our forecasts, a long-term increase is expected, the "DRIP" stock price prognosis for 2027-07-05 is 35.991 USD. With a 5-year investment, the revenue is expected to be around +47.5%. Your current $100 investment may be up to $147.5 in 2027.
Is DRIP ETF a good investment?
DRIP is not a long term instrument and is not suitable for buy-and-hold investors. The fund lost more than 70% in the past year. Utilized with thoughtfulness and on a very short-term basis (1-2 days) this ETF can generate substantial returns due to its leverage.
How has Direxion Daily S&P Biotech Bear 3x Shares' stock performed in 2022?
Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $25.74 on January 1st, 2022. Since then, LABD stock has increased by 125.3% and is...
When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? How did Direxion Daily S&P Biotech Bear 3x Shares' stock split work?
Direxion Daily S&P Biotech Bear 3x Shares's stock reverse split on Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 2...
What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bear 3x Shares investors own inc...
What is Direxion Daily S&P Biotech Bear 3x Shares' stock symbol?
Direxion Daily S&P Biotech Bear 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LABD."
Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders?
Direxion Daily S&P Biotech Bear 3x Shares' stock is owned by many different retail and institutional investors. Top institutional shareholders incl...
Which major investors are selling Direxion Daily S&P Biotech Bear 3x Shares stock?
LABD stock was sold by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Goldman Sachs Group Inc., Jane Stre...
Which major investors are buying Direxion Daily S&P Biotech Bear 3x Shares stock?
LABD stock was acquired by a variety of institutional investors in the last quarter, including Livingston Group Asset Management CO operating as So...
How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares?
Shares of LABD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Direxion Daily S&P Biotech Bear 3x Shares' stock price today?
One share of LABD stock can currently be purchased for approximately $58.00.
When did the stock market get boosted?
The market was further boosted at the end of 2017 and into the beginning of 2018 by the Republican tax cut package Trump signed into law at the end of last year.
How much has the Dow Jones lost?
Since the beginning of the year, the Dow Jones Industrial Average has lost about 10 percent of its value, as did the S&P 500. The Nasdaq dropped roughly 8 percent. The vast majority of losses have come since October, when the stock market, which was experiencing the longest bull run in history, took a turn for the worst.
Why is the Federal Reserve tightening its monetary policy?
That reduces liquidity in the market, creating obstacles for obtaining credit and loans — factors that could slow down the global economy.
Which companies have been criticized for not doing more to help block Russian interference in the 2016 election?
Congress has focused in particular on companies like Google, Twitter and Facebook, which have been criticized for not doing more to help block Russian interference in the 2016 election. Facebook and other major tech companies faced greater scrutiny in 2018, including from lawmakers in Congress.
Who said the nation's banks have plenty of money to lend?
Over the weekend Treasury Secretary Steven Mnuchin attempted to alleviate concerns about a tightening credit market, saying that the nation’s major banks have plenty of money to lend.
Did Trump spare any country from the tariffs?
In May, Trump decided not to spare any country –including U.S. allies — from the steel and aluminum tariffs. The trade war, which has centered on China, continued to escalate until Trump and China’s President Xi Jinping agreed earlier this month to hold off on imposing new tariffs for 90 days.
Is the stock market an economy?
The stock market is not the economy. It’s worth remembering that there is a fundamental difference between economic indicators like the unemployment rate and the stock market. The economic indicators are backwards looking; they tell us what the unemployment rate was in the last few weeks or months.
How much did the S&P 500 rise in 2009?
Since March 9, 2009, the S&P 500 rose 268 percent . The market gains in the first year of Trump’s presidency were part of a longer climb that began after March 3, 2009, when it bottomed out during the Great Recession. Markets have been on a steady upswing since then, the longest period of optimism and investor confidence ever.
When did the S&P 500 hit its peak?
The housing market had already been dragging down stocks, but the S&P 500 reached its pre-Great Recession peak in October 2007. The markets boomed around news that interest rates would be cut by half a point, surpassing investor expectations.
When did the S&P 500 reach its all time high?
Better-than-expected earnings reports led the S&P 500 to an all-time high on Jan. 26, one of many record highs across the year culminating with a final peak on Sept. 20. March 21, 2018 June 13, 2018 Sept. 26, 2018 Dec. 19, 2018.
How has Direxion Daily S&P Biotech Bear 3x Shares' stock been impacted by COVID-19 (Coronavirus)?
Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $364.60 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LABD stock has decreased by 88.3% and is now trading at $42.82. View which stocks have been most impacted by COVID-19.
When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? How did Direxion Daily S&P Biotech Bear 3x Shares' stock split work?
Direxion Daily S&P Biotech Bear 3x Shares shares reverse split on Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 27th 2020.
What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bear 3x Shares investors own include Direxion Daily S&P Biotech Bull 3x Shares (LABU), Micron Technology (MU), Intel (INTC), Gilead Sciences (GILD), Sanofi (SNY), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Pfizer (PFE), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and ProShares UltraPro Short QQQ (SQQQ)..
What is Direxion Daily S&P Biotech Bear 3x Shares' stock symbol?
Direxion Daily S&P Biotech Bear 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LABD."
Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders?
Direxion Daily S&P Biotech Bear 3x Shares' stock is owned by a variety of retail and institutional investors. Top institutional investors include Susquehanna International Group LLP (0.00%), Virtu Financial LLC (6.70%), Citadel Advisors LLC (0.00%), Wolverine Trading LLC (0.00%), Goldman Sachs Group Inc. (1.76%) and Goldman Sachs Group Inc.
Which major investors are selling Direxion Daily S&P Biotech Bear 3x Shares stock?
LABD stock was sold by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP, Cutler Group LP, and Wolverine Trading LLC.
Which major investors are buying Direxion Daily S&P Biotech Bear 3x Shares stock?
LABD stock was purchased by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Goldman Sachs Group Inc., Virtu Financial LLC, Bank of America Corp DE, Flow Traders U.S. LLC, and Citadel Advisors LLC.
The company's soft outlook for the holiday quarter ruined what was a solid year overall for the leading game maker
It was an up and down year for the Call of Duty maker last year. Activision Blizzard 's ( NASDAQ:ATVI) momentum in the first half of the year was wiped out in the last three months by market turbulence and concerns about weak engagement in its core franchises.
What happened
Through the first three quarters of 2018, Activision grew total revenue 2.9% year over year to $5.1 billion, which was in line with expectations. Adjusted earnings per share have exceeded Wall Street's expectations over the last four quarters.
So what
In early October, the broader market got shaky, as concerns arose about the health of the overall economy, and this wiped out Activision's gains in the first half of the year. Shares declined 26.5% in value in 2018, according to data provided by S&P Global Market Intelligence.
Now what
Management's full-year guidance calls for revenue to grow 2.7% year over year to $7.355 billion and for adjusted EPS to climb 7.9% year over year to $2.46. With the stock price cut down by nearly half from its 2018 high, the valuation on the shares is more appealing at a P/E of 19.5 times management's full-year adjusted earnings guidance for 2018.
Who replaced Jeffrey Immelt?
The story here goes back to the GE board replacing longtime CEO Jeffrey Immelt with insider John Flannery in June 2017. It was something of a surprise move, but not overly shocking as investors had been losing patience with Immelt's turnaround efforts.
Is Culp still at the helm?
Culp has only been at the helm for a few months at this point, so he hasn't had a lot of time to implement his big plans to save GE. In other words, there's still a lot of work to be done. As such, it's best to look at General Electric as a turnaround story.
What happened
The maker of The Sims and FIFA 19 enjoyed tremendous momentum in the first half of 2018.
So what
Throughout 2018, there were questions about whether megapopular battle royale games were taking players away from the major game companies like EA and Activision Blizzard ( NASDAQ:ATVI).
Now what
For fiscal 2019, management is calling for total revenue of $5.15 billion, representing flat year-over-year growth. This is due to the one-month delay of Battlefield V, which will push some of that game's revenue into 2019, as well as the reduced expectations for in-game spending in sports titles.
Why did Nvidia stock drop in October?
The major market sell-off in October that hit highly valued tech stocks particularly hard. Concerns about rising interest rates, a slowing global economy -- and particularly slowing demand for semiconductors -- and the escalating trade war with China were likely the main reasons for the market jitters. NVIDIA stock declined 25% in October.
How much did Nvidia stock return in 2019?
As for 2019, NVIDIA stock has returned 11.5%, through Friday, Jan. 11, when it closed at $148.83. That's much better than the S&P 500's 3.6% return, but it's still 49% off NVIDIA stock's all-time closing high of $289.07, set on Oct. 1, 2018. Here's what investors should know.